MetaCap

Translational Development Acquisition Corp. (TDAC)

NASDAQ: TDACFinancial ServicesShell CompaniesUSD

10.85+0.05 (+0.46%)

Market open · Delayed 15 min · as of Oct 8, 10:43 AM ET

TDAC stock chart

Technical analysis

Key statistics

All statistics
Market cap
$209.50M
52-week range
10.35 – 10.95
Day range
10.80 – 10.85
Volume / Avg
2.04K / 27.88K
Beta
—

52-week range

$10.35$10.95

TDAC stock today

Translational Development Acquisition (TDAC) is trading at $10.85 on Oct 8, up 0.46% (+$0.05), versus the S&P 500's 0.36% decline. At this level, TDAC sits near the top of its 52-week range of $10.35 to $10.95: 0.9% below the high and 4.8% above the low. Translational Development Acquisition trades at 41.7x its trailing twelve-month earnings per share of $0.26.

Summary generated from market data by MetaCap's automated system. Methodology

About Translational Development Acquisition

Company profile

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Industry
Shell Companies
CEO
Mr. Michael M. B. Hoffman J.D.
Headquarters
New York, NY
IPO year
2025

Translational Development Acquisition peers

Financial Services sector

Indexes, lists and sector

Translational Development Acquisition stock FAQ

What is Translational Development Acquisition's stock price today?

TDAC last traded at $10.85 as of Oct 8, 10:43 AM EDT, up 0.46% on the day. Prices are delayed at least 15 minutes.

What is TDAC's P/E ratio?

TDAC trades at a trailing P/E ratio of 41.73.

Who is Translational Development Acquisition's CEO?

Mr. Michael M. B. Hoffman J.D. is the chief executive officer of Translational Development Acquisition Corp..

What is the TDAC 52-week high?

The 52-week high for TDAC is $10.95 and the 52-week low is $10.35. The stock is currently 0.9% below its high.

Compare TDAC